Mammalian target of rapamycin as a novel target in the treatment of hepatocellular carcinoma.
Guo
Yu
Y
Department of VIP healthcare Center, The Third Affiliated Hospital of Sun-Yat-Sen University, Guangzhou 510630, PR China.
Liang
Xinjun
X
Lu
Minqiang
M
Weng
Taohua
T
Liu
Yanyan
Y
Ye
Xiaoming
X
D000970:Antineoplastic Agents / Q000494:pharmacology; D016375:Antisense Elements (Genetics); D017209:Apoptosis / Q000187:drug effects / Q000502:physiology; D006528:Carcinoma, Hepatocellular / Q000188:drug therapy / Q000378:metabolism* / Q000473:pathology; D045744:Cell Line, Tumor; D002465:Cell Movement / Q000187:drug effects; D049109:Cell Proliferation / Q000187:drug effects; D015972:Gene Expression Regulation, Neoplastic / Q000502:physiology; D005822:Genetic Vectors; D049452:Green Fluorescent Proteins; D006801:Humans; D008113:Liver Neoplasms / Q000188:drug therapy / Q000378:metabolism* / Q000473:pathology; D009361:Neoplasm Invasiveness; D010957:Plasmids; D051057:Proto-Oncogene Proteins c-akt / Q000378:metabolism; D058570:TOR Serine-Threonine Kinases / Q000187:drug effects / Q000502:physiology*; D014162:Transfection
D000970:Antineoplastic Agents; D016375:Antisense Elements (Genetics); C485184:enhanced green fluorescent protein; D049452:Green Fluorescent Proteins; C546842:MTOR protein, human; D051057:Proto-Oncogene Proteins c-akt; D058570:TOR Serine-Threonine Kinases